{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:55:57Z","timestamp":1792119357289,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7516","license":[{"start":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:00:00Z","timestamp":1404259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:00:00Z","timestamp":1404259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2014,9,4]]},"DOI":"10.1038\/nature13441","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T05:52:07Z","timestamp":1404193927000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":426,"title":["Mutant IDH inhibits HNF-4\u03b1 to block hepatocyte differentiation and promote biliary cancer"],"prefix":"10.1038","volume":"513","author":[{"given":"Supriya K.","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Parachoniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna S.","family":"Ghanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Fitamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortada S.","family":"Najem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Gurumurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra A.","family":"Akbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cornella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Miltiadous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Walesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram F.","family":"Hezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine E.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly S.","family":"Straley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Travins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeta","family":"Popovici-Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Gliser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udayan","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Llovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Bardeesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,2]]},"reference":[{"key":"BFnature13441_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","volume":"17","author":"DR Borger","year":"2012","unstructured":"Borger, D. R. et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17, 72\u201379 (2012)","journal-title":"Oncologist"},{"key":"BFnature13441_CR2","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","volume":"28","author":"AF Hezel","year":"2010","unstructured":"Hezel, A. F., Deshpande, V. & Zhu, A. X. Genetics of biliary tract cancers and emerging targeted therapies. J. Clin. Oncol. 28, 3531\u20133540 (2010)","journal-title":"J. Clin. Oncol."},{"key":"BFnature13441_CR3","doi-asserted-by":"publisher","unstructured":"Razumilava, N. & Gores, G. J. Cholangiocarcinoma. Lancet http:\/\/dx.doi.org\/10.1016\/S0140-6736(13)61903-0 (2014)","DOI":"10.1016\/S0140-6736(13)61903-0"},{"key":"BFnature13441_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.humpath.2012.11.006","volume":"44","author":"JS Voss","year":"2013","unstructured":"Voss, J. S. et al. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Hum. Pathol. 44, 1216\u20131222 (2013)","journal-title":"Hum. Pathol."},{"key":"BFnature13441_CR5","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/onc.2012.315","volume":"32","author":"P Wang","year":"2013","unstructured":"Wang, P. et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091\u20133100 (2013)","journal-title":"Oncogene"},{"key":"BFnature13441_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744 (2009)","journal-title":"Nature"},{"key":"BFnature13441_CR7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1101\/gad.217406.113","volume":"27","author":"JA Losman","year":"2013","unstructured":"Losman, J. A. & Kaelin, W. G., Jr What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27, 836\u2013852 (2013)","journal-title":"Genes Dev."},{"key":"BFnature13441_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474\u2013478 (2012)","journal-title":"Nature"},{"key":"BFnature13441_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature11323","volume":"488","author":"M Sasaki","year":"2012","unstructured":"Sasaki, M. et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656\u2013659 (2012)","journal-title":"Nature"},{"key":"BFnature13441_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17\u201330 (2011)","journal-title":"Cancer Cell"},{"key":"BFnature13441_CR11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cphy.c120014","volume":"3","author":"GK Michalopoulos","year":"2013","unstructured":"Michalopoulos, G. K. Principles of liver regeneration and growth homeostasis. Compr Physiol 3, 485\u2013513 (2013)","journal-title":"Compr Physiol"},{"key":"BFnature13441_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.devcel.2010.01.011","volume":"18","author":"K Si-Tayeb","year":"2010","unstructured":"Si-Tayeb, K., Lemaigre, F. P. & Duncan, S. A. Organogenesis and development of the liver. Dev. Cell 18, 175\u2013189 (2010)","journal-title":"Dev. Cell"},{"key":"BFnature13441_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1053\/jhep.2002.36123","volume":"36","author":"H Strick-Marchand","year":"2002","unstructured":"Strick-Marchand, H. & Weiss, M. C. Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology 36, 794\u2013804 (2002)","journal-title":"Hepatology"},{"key":"BFnature13441_CR14","doi-asserted-by":"publisher","first-page":"13717","DOI":"10.1074\/jbc.M113.511030","volume":"289","author":"MI Davis","year":"2014","unstructured":"Davis, M. I. et al. Biochemical, cellular and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1. J. Biol. Chem. 289, 13717\u201313725 (2014)","journal-title":"J. Biol. Chem."},{"key":"BFnature13441_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/355457a0","volume":"355","author":"CJ Kuo","year":"1992","unstructured":"Kuo, C. J. et al. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355, 457\u2013461 (1992)","journal-title":"Nature"},{"key":"BFnature13441_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0925-4773(01)00521-4","volume":"109","author":"ME Torres-Padilla","year":"2001","unstructured":"Torres-Padilla, M. E., Fougere-Deschatrette, C. & Weiss, M. C. Expression of HNF4\u03b1 isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3\u2032 end splicing. Mech. Dev. 109, 183\u2013193 (2001)","journal-title":"Mech. Dev."},{"key":"BFnature13441_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng1001","volume":"32","author":"O Bluteau","year":"2002","unstructured":"Bluteau, O. et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nature Genet. 32, 312\u2013315 (2002)","journal-title":"Nature Genet."},{"key":"BFnature13441_CR18","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1074\/jbc.M111.334599","volume":"287","author":"JA Bonzo","year":"2012","unstructured":"Bonzo, J. A., Ferry, C. H., Matsubara, T., Kim, J. H. & Gonzalez, F. J. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4\u03b1 in adult mice. J. Biol. Chem. 287, 7345\u20137356 (2012)","journal-title":"J. Biol. Chem."},{"key":"BFnature13441_CR19","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1128\/MCB.01389-08","volume":"29","author":"JM Servitja","year":"2009","unstructured":"Servitja, J. M. et al. Hnf1\u03b1 (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver. Mol. Cell. Biol. 29, 2945\u20132959 (2009)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature13441_CR20","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/hep.26251","volume":"57","author":"C Walesky","year":"2013","unstructured":"Walesky, C. et al. Hepatocyte nuclear factor 4\u03b1 deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology 57, 2480\u20132490 (2013)","journal-title":"Hepatology"},{"key":"BFnature13441_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1101\/gad.207803.112","volume":"27","author":"K Yanger","year":"2013","unstructured":"Yanger, K. et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev. 27, 719\u2013724 (2013)","journal-title":"Genes Dev."},{"key":"BFnature13441_CR22","first-page":"103","volume":"79","author":"KH Preisegger","year":"1999","unstructured":"Preisegger, K. H. et al. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab. Invest. 79, 103\u2013109 (1999)","journal-title":"Lab. Invest."},{"key":"BFnature13441_CR23","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI59261","volume":"121","author":"Y Malato","year":"2011","unstructured":"Malato, Y. et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J. Clin. Invest. 121, 4850\u20134860 (2011)","journal-title":"J. Clin. Invest."},{"key":"BFnature13441_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1101\/gad.2027811","volume":"25","author":"S Shin","year":"2011","unstructured":"Shin, S. et al. Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev. 25, 1185\u20131192 (2011)","journal-title":"Genes Dev."},{"key":"BFnature13441_CR25","doi-asserted-by":"crossref","unstructured":"Genomic. and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013)","DOI":"10.1056\/NEJMoa1301689"},{"key":"BFnature13441_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","volume":"72","author":"MR O\u2019Dell","year":"2012","unstructured":"O\u2019Dell, M. R. et al. Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. Cancer Res. 72, 1557\u20131567 (2012)","journal-title":"Cancer Res."},{"key":"BFnature13441_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.bjc.6606011","volume":"104","author":"J Avruch","year":"2011","unstructured":"Avruch, J., Zhou, D., Fitamant, J. & Bardeesy, N. Mst1\/2 signalling to Yap: gatekeeper for liver size and tumour development. Br. J. Cancer 104, 24\u201332 (2011)","journal-title":"Br. J. Cancer"},{"key":"BFnature13441_CR28","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/leu.2010.113","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi, A. et al. IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 24, 1302\u20131309 (2010)","journal-title":"Leukemia"},{"key":"BFnature13441_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149\u20131153 (2009)","journal-title":"Am. J. Pathol."},{"key":"BFnature13441_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V","volume":"26","author":"C Postic","year":"2000","unstructured":"Postic, C. & Magnuson, M. A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26, 149\u2013150 (2000)","journal-title":"Genesis"},{"key":"BFnature13441_CR31","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gni051","volume":"33","author":"G Belteki","year":"2005","unstructured":"Belteki, G. et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33, e51 (2005)","journal-title":"Nucleic Acids Res."},{"key":"BFnature13441_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/gene.20180","volume":"44","author":"C Beard","year":"2006","unstructured":"Beard, C., Hochedlinger, K., Plath, K., Wutz, A. & Jaenisch, R. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44, 23\u201328 (2006)","journal-title":"Genesis"},{"key":"BFnature13441_CR33","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.0610593104","volume":"104","author":"E Giacometti","year":"2007","unstructured":"Giacometti, E., Luikenhuis, S., Beard, C. & Jaenisch, R. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl Acad. Sci. USA 104, 1931\u20131936 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13441_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nature Genet. 38, 500\u2013501 (2006)","journal-title":"Nature Genet."},{"key":"BFnature13441_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia, D. et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144, 829\u2013840 (2013)","journal-title":"Gastroenterology"},{"key":"BFnature13441_CR36","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/hep.25890","volume":"56","author":"N Oishi","year":"2012","unstructured":"Oishi, N. et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56, 1792\u20131803 (2012)","journal-title":"Hepatology"},{"key":"BFnature13441_CR37","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1158\/0008-5472.CAN-07-1369","volume":"67","author":"JS Kang","year":"2007","unstructured":"Kang, J. S., Wanibuchi, H., Morimura, K., Gonzalez, F. J. & Fukushima, S. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res. 67, 11141\u201311146 (2007)","journal-title":"Cancer Res."},{"key":"BFnature13441_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","volume":"71","author":"L Verna","year":"1996","unstructured":"Verna, L., Whysner, J. & Williams, G. M. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol. Ther. 71, 57\u201381 (1996)","journal-title":"Pharmacol. Ther."}],"updated-by":[{"DOI":"10.1038\/nature16136","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000}},{"DOI":"10.1038\/nature14149","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature13441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13441","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:22:04Z","timestamp":1684419724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature13441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,2]]},"references-count":38,"journal-issue":{"issue":"7516","published-print":{"date-parts":[[2014,9,4]]}},"alternative-id":["BFnature13441"],"URL":"https:\/\/doi.org\/10.1038\/nature13441","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,2]]},"assertion":[{"value":"25 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2015","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/nature14149","URL":"https:\/\/doi.org\/10.1038\/nature14149","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.Y., K.S., J.T., J.P.-M. and C.G. are employees of Agios Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}